Safe Administration of Nitroglycerin: Evidence‑Based Recommendations

Hemodynamic Contraindications

Avoid nitroglycerin when systolic blood pressure is < 90 mmHg or falls ≥ 30 mmHg below the patient’s baseline; such hypotension predicts severe adverse events. 1
Do not give nitroglycerin to patients with severe bradycardia (heart rate < 50 bpm) because the drug can exacerbate low cardiac output. 1
Refrain from nitroglycerin use in tachycardic patients (heart rate > 100 bpm) who do not have heart failure, as the combination may precipitate hemodynamic instability. 1
Always verify blood pressure before treating chest pain with nitroglycerin; administering the drug in the presence of hypotension is an absolute contraindication even when pain is severe. [1][2]

Combine nitroglycerin with other vasodilators or antihypertensive agents only under strict blood‑pressure monitoring, because additive vasodilatory effects can cause profound hypotension. 3
Patients already receiving calcium‑channel blockers, ACE inhibitors, or other antihypertensive medications need close hemodynamic observation when nitroglycerin is added. 3
Concurrent use of morphine (or other opiates) with nitroglycerin increases the risk of hypotension, as opiates act as venodilators that further reduce preload. 3
When morphine is administered with nitroglycerin, avoid cyclizine as an anti‑emetic because its vasoconstrictive properties may counteract the intended vasodilatory effect of nitroglycerin. 3

In patients with significant mitral or aortic stenosis, nitroglycerin should be used only with great caution; these individuals rely on adequate preload, and vasodilation can precipitate hemodynamic collapse. 3

Obtain a right‑sided ECG in inferior‑wall STEMI before giving any nitrate; this diagnostic step identifies RV infarction, a condition where nitroglycerin is contraindicated because patients are preload‑dependent. 2

The American College of Cardiology and American Heart Association recommend that nitrates should not be administered to patients with systolic blood pressure less than 90 mm Hg, systolic blood pressure ≥30 mm Hg below baseline, severe bradycardia, tachycardia, or suspected right ventricular infarction 4
The American College of Cardiology notes that inadvertent systemic hypotension with resulting worsening of myocardial ischemia is the most serious potential complication of nitroglycerin therapy in patients with acute myocardial infarction 5, 6

The American College of Cardiology advises that nitroglycerin should be used with extreme caution or avoided entirely in patients with suspected right ventricular infarction, as these patients are especially dependent on adequate right ventricular preload to maintain cardiac output 5, 6
A right-sided ECG should be performed to evaluate for RV infarction before administering nitrates in inferior STEMI 7

The 1990 American College of Cardiology and American Heart Association guidelines note that even if systolic blood pressure is <90 mm Hg, a single sublingual nitroglycerin tablet may be tried in the hospital provided there is evidence of ongoing ischemic pain and an intravenous line has been inserted 6
The American College of Cardiology recommends establishing IV access immediately and considering fluid resuscitation if appropriate for the clinical scenario 5, 6
The American College of Cardiology suggests administering aspirin 162-325 mg (chewed) if no contraindications, and considering morphine sulfate (2-4 mg IV) for pain relief instead 4